Skip to main content

Day: April 1, 2026

Treasure Global’s Subsidiary Tadaa Technologies Partners with Anhui Fuyuan Group to Accelerate Global Drone and Electric Mobility Expansion

Malaysia hub to serve Europe and North America, targeting scalable global distribution and next-generation defense applications KUALA LUMPUR, Malaysia, April 01, 2026 (GLOBE NEWSWIRE) — Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a Southeast Asia–anchored technology company, today announced that its subsidiary, Tadaa Technologies Sdn Bhd has signed a strategic Memorandum of Understanding (MOU) with Anhui Fuyuan Electromechanical Technology Co. Ltd., establishing a framework to explore expansion into high-growth electric mobility and advanced technology markets. Under the MOU, the collaboration is intended to explore a Malaysia-based hub for electric mobility solutions, with potential expansion into military-grade drones and next-generation mobility technologies, serving Europe and North America. Leveraging...

Continue reading

Crane NXT Completes Acquisition of Antares Vision

Adds Market-Leading Capabilities in Detection, Inspection, and Traceability Technologies Expands Crane NXT’s Portfolio into the ~$3 Billion Life Sciences and Food & Beverage Sectors WALTHAM, Mass., April 01, 2026 (GLOBE NEWSWIRE) — Crane NXT, Co. (NYSE: CXT) (“Crane NXT” or the “Company”), a global leader in authentication and traceability technologies, today announced the successful completion of the acquisition of Antares Vision S.p.A. (“Antares Vision”). Antares Vision has been delisted from the Euronext Milan stock exchange and is now a wholly owned subsidiary of the Company. Aaron W. Saak, Crane NXT’s President and Chief Executive Officer, stated: “The acquisition of Antares Vision is an important milestone in the continued evolution of Crane NXT. Antares Vision’s market-leading technology, software, and service offerings...

Continue reading

Avicanna Reports Full Year 2025 Audited Financial Statements

Achieved positive adjusted EBITDA in Q4 2025 and near break-even $(0.29) million for the full year Advancements across business units, R&D, and clinical development to support scale and international growth TORONTO, April 01, 2026 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products is pleased to announce that its full year 2025 results, audited financial statements with management’s discussion and analysis have been filed. “Throughout the year, we strengthened our leadership in cannabinoid-based medicine by advancing our research and development programs, progressing clinical initiatives, and deepening engagement with the Canadian medical community....

Continue reading

RenX Enterprises Corp. Beats Revenue Guidance, Delivering $8.2 Million in Post-Acquisition Revenue While Completing Full Platform Buildout and Retiring $11.9 Million in Legacy Debt

MIAMI, April 01, 2026 (GLOBE NEWSWIRE) — RenX Enterprises Corp. (NASDAQ: RENX) today announced financial results for the fiscal year ended December 31, 2025. The growing media and substrate industry runs on imported raw materials. Peat is harvested in Canada and Eastern Europe. Coconut coir is processed in Southeast Asia. Both travel thousands of miles before they reach a North American greenhouse or a bag on a retail shelf. Producers who depend on this supply chain are facing a structural problem: input costs are rising, import dependencies are deepening, and sourcing alternatives quickly is not straightforward. The industry has been waiting for a domestic solution that can produce at scale, at the right quality, and at a cost that makes the import dependency look like what it increasingly is: a disadvantage. RenX was built to...

Continue reading

Watsco Declares $3.30 Quarterly Dividend

Reflects 10% Increase to Annual Rate of $13.20 Per Share MIAMI, April 01, 2026 (GLOBE NEWSWIRE) — Watsco, Inc.’s (NYSE: WSO) Board of Directors has declared a regular quarterly cash dividend of $3.30 on each outstanding share of its Common and Class B common stock payable on April 30, 2026 to shareholders of record at the close of business on April 16, 2026. This marks a 10% increase to an annual rate of $13.20 per share. Albert H. Nahmad, Watsco’s Chairman & CEO stated: “We are pleased to increase dividends to shareholders, reflecting our continued confidence in our business, which is fundamentally supported by our strong balance sheet.” Watsco has paid dividends to shareholders for 52 consecutive years. The Company’s philosophy is to share cash flow through dividends while maintaining a conservative balance sheet with continued...

Continue reading

Brookfield Infrastructure to Host First Quarter 2026 Results Conference Call

BROOKFIELD, NEWS, April 01, 2026 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners will hold its first quarter 2026 conference call and webcast on Wednesday, April 29, 2026, at 9:00 a.m. (ET). Results will be released that morning before 7:00 a.m. (ET) and will be available on our website at https://bip.brookfield.com. Participants can join by conference call or webcast. Conference CallPlease pre-register at: BIP2026Q1ConferenceCall Upon registering, you will be emailed a dial-in number and unique PIN. This process will bypass the operator and avoid the queue.WebcastPlease join and register at: BIP2026Q1WebcastAbout Brookfield Infrastructure Brookfield Infrastructure is a leading global infrastructure company that owns and operates high-quality, long-life assets in the utilities, transport, midstream and data sectors...

Continue reading

Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting

BOSTON and SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced that it will present results from its Phase 2a trial of RAP-219 in patients with focal onset seizures (FOS), including new data from the 8-week follow-up period, in a podium presentation at the upcoming 2026 American Academy of Neurology (AAN) Annual Meeting, taking place April 18-22 in Chicago. Presentation DetailsTitle: Efficacy and Tolerability of RAP-219, a Potential First-in-Class Negative Allosteric Modulator of γ8 Transmembrane AMPA Receptor Regulatory Protein: Impact on RNS Long Episodes and Clinical Seizures Presenter: William...

Continue reading

CLEAN Announces Premier American Uranium as a Silver Sponsor of the 1st Annual Nuclear in New Mexico Conference

SANTA FE, N.M. and TORONTO, April 01, 2026 (GLOBE NEWSWIRE) — The Clean Energy Association of New Mexico (“CLEAN”) and Premier American Uranium (“PUR”, the “Company” or “Premier American Uranium”) (TSXV: PUR) (OTCQB: PAUIF) are pleased to announce that PUR will serve as a Silver Sponsor of the inaugural Nuclear in New Mexico: Fueling the U.S. Nuclear Renaissance conference. The conference is taking place April 20th to 22nd, 2026, at the Hyatt Regency Tamaya Resort & Spa, located on the Santa Ana Pueblo just north of Albuquerque, New Mexico. Colin Healey, CEO of Premier American Uranium Inc., commented, “We are proud to support the inaugural Nuclear in New Mexico Conference, particularly as we continue to advance our Cebolleta Project. Following the completion of our robust PEA last year, our 2026 programs are focused on further...

Continue reading

 Green Thumb Industries Announces Amendment to Brand Transactions with RYTHM, Inc.

CHICAGO and VANCOUVER, British Columbia, April 01, 2026 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced amendments to its brand licensing agreements with wholly-owned subsidiaries of RYTHM, Inc. (“RYTHM” or “RYM”) (Nasdaq: RYM). Effective April 1, 2026, GTI Core, LLC (“GTI Core”), an indirect wholly-owned subsidiary of the Company, has amended its existing Trademark and Recipe License Agreements with VCP IP Holdings, LLC and MC Brands LLC, both wholly-owned subsidiaries of RYTHM. Under the amended agreements, licensing fees transition from revenue-based fees to recurring fixed fees of $70 million cash per year collectively for the license rights to RYTHM...

Continue reading

RYTHM, Inc. Announces Amendments to License Agreements with Green Thumb Industries

ROLLING MEADOWS, Ill., April 01, 2026 (GLOBE NEWSWIRE) — RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company, today announced amendments to its existing trademark and recipe license agreements with an indirect wholly-owned subsidiary of Green Thumb Industries Inc. (“Green Thumb”). RYTHM and Green Thumb have amended their existing trademark and recipe license agreements for the use of brand intellectual property which includes RYTHM, incredibles, Beboe, Dogwalkers, Doctor Solomon’s, &Shine, and Good Green. Effective April 1, 2026, Green Thumb will pay RYTHM an aggregate fixed annual cash fee of $70 million, subject to an annual increase equal to two times a Consumer Price Index-based escalator. “These amendments create a framework that strengthens our licensing arrangement with Green Thumb over the long...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.